Some aspects of the angiotensin-converting enzyme for leukemias


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The present article shows the diagnosis of different type leukemias in children by the activity of angiotensin-converting enzyme in blood serum to be not promising. Beside that, enalaprilat, carboxylate inhibitor of ACE, exhibited no specific cytotoxic activity against cancer cells; moreover, in the case of chronic myeloleukemia (K-562) and T-cell acute lymphoblastic leukemia (MOLT-4), its weak protective action against cancer cells was noted.

Авторлар туралы

M. Orlova

Department of Chemistry, M. V. Lomonosov Moscow State University; Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology, and Immunology

Хат алмасуға жауапты Автор.
Email: orlova.radiochem@mail.ru
Ресей, Build. 3, 1 Leninskie Gory, Moscow, 119992; 1 ul. Samory Mashela, Moscow, 117997

A. Orlov

Department of Chemistry, M. V. Lomonosov Moscow State University

Email: orlova.radiochem@mail.ru
Ресей, Build. 3, 1 Leninskie Gory, Moscow, 119992

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media New York, 2016